Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EEF1A1P40 is a processed pseudogene of the parent gene eukaryotic translation elongation factor 1 alpha 1 (EEF1A1), located in the human genome but not encoding a functional protein product[1][3]. Processed pseudogenes arise from the reverse transcription and integration of mRNA from a parent gene without introns. While most pseudogenes like EEF1A1P40 are considered non-coding and biologically inert, there is growing interest in their possible roles in modulating parent gene activity and disease, including cancer, through regulatory RNA mechanisms[3]. EEF1A1 itself encodes a key GTPase protein that mediates aminoacyl-tRNA delivery to ribosomes during protein biosynthesis and has various non-canonical cellular functions[2][3][4]. The pseudogenes of EEF1A1, including EEF1A1P40, are numerous and typically classified as retropseudogenes distributed throughout the human genome[3]. Specific functional or disease associations for EEF1A1P40 have not been documented in peer-reviewed literature as of the present date.
None; not a drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic Translation Elongation Factor 1 Alpha 1 Pseudogene 40 (EEF1A1P40).